The Role of Cetuximab in the Treatment of Metastatic Colorectal Cancer

被引：0
|
作者：
Holubec, Lubos [1 ]
Liska, Vaclav [2 ]
Matejka, Vit M. [1 ]
Fiala, Ondrej [1 ]
Dreslerova, Jana [1 ]
Mrazkova, Petra [3 ,4 ]
Treska, Vladislav [2 ]
Finek, Jindrich [1 ]
机构：
[1] Charles Univ Prague, Dept Oncol & Radiotherapy, Sch Med, Prague, Czech Republic
[2] Charles Univ Prague, Dept Surg, Sch Med, Prague, Czech Republic
[3] Charles Univ Prague, Dept Radiol, Sch Med, Prague, Czech Republic
[4] Charles Univ Prague, Teaching Hosp Pilsen, Prague, Czech Republic
来源：
ANTICANCER RESEARCH | 2012年 / 32卷 / 09期
关键词：
KRAS; cetuximab; colorectal cancer; liver metastases; review; PLUS IRINOTECAN; 1ST-LINE TREATMENT; COMBINATION CHEMOTHERAPY; NEOADJUVANT CHEMOTHERAPY; LIVER METASTASES; OXALIPLATIN; FLUOROPYRIMIDINE; LEUCOVORIN; RESECTION;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Targeted biological therapy is becoming a standard in personalized medicine for patients with advanced stages of cancer. Treatment with cetuximab, an anti-epidermal growth factor receptor (EGFR) antibody, represents an example of personalized anticancer the for patients with metastatic colorectal cancer and wild (non-mutated) type of the Kirsten rat sarcoma viral oncogene (KRAS). Here the role of cetuximab in treating metastatic colorectal cancer is discussed with a focus on the treatment of hepatic metastases.
引用
收藏
页码：4007 / 4011
页数：5
相关论文
共 50 条
  • [1] Role of cetuximab and sorafenib in treatment of metastatic colorectal cancer
    Galal, K. M.
    Khaled, Z.
    Mourad, Abdel Monem M.
    INDIAN JOURNAL OF CANCER, 2011, 48 (01) : 47 - 54
  • [2] Cetuximab - In the treatment of metastatic colorectal cancer
    Reynolds, NA
    Wagstaff, AJ
    DRUGS, 2004, 64 (01) : 109 - 118
  • [3] Cetuximab for treatment of metastatic colorectal cancer
    Cerea, G.
    Ricotta, R.
    Schiavetto, I.
    Maugeri, M. R.
    Sartore-Bianchi, A.
    Moroni, M.
    Artale, S.
    Siena, S.
    ANNALS OF ONCOLOGY, 2006, 17 : VII66 - VII67
  • [4] Cetuximab in the treatment of metastatic colorectal cancer
    Moosmann, Nicolas
    Heinemann, Volker
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (02) : 243 - 256
  • [5] Metastatic colorectal cancer. Role of cetuximab
    Marmesat Rodas, Barbara
    Villa Rubio, Alberto
    Gallego Galisteo, Myriam
    Guerra Estevez, Dulce
    Marquez Fernandez, Eloisa
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (01) : 286 - 287
  • [6] Role of cetuximab in first-line treatment of metastatic colorectal cancer
    Miguel Jhonatan Sotelo
    Beatriz García-Paredes
    Carlos Aguado
    Javier Sastre
    Eduardo Díaz-Rubio
    World Journal of Gastroenterology, 2014, (15) : 4208 - 4219
  • [7] Role of cetuximab in first-line treatment of metastatic colorectal cancer
    Sotelo, Miguel Jhonatan
    Garcia-Paredes, Beatriz
    Aguado, Carlos
    Sastre, Javier
    Diaz-Rubio, Eduardo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (15) : 4208 - 4219
  • [8] Impact of cetuximab in current treatment of metastatic colorectal cancer
    Sotelo Lezama, Miguel Jhonatan
    Sastre Valera, Javier
    Diaz-Rubio Garcia, Eduardo
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (03) : 387 - 399
  • [9] Cetuximab in first line treatment of metastatic colorectal cancer
    Barone, Carlo
    Belisari, Andrea
    Ciardiello, Fortunato
    D'Angiolella, Lucia
    Furneri, Gianluca
    Mantovani, Lorenzo
    Normanno, Nicola
    Piacentini, Patrizio
    Pinto, Carmine
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2012, 13 : 3 - 78
  • [10] Cetuximab treatment in a patient with metastatic colorectal cancer and psoriasis
    Neyns, B.
    Meert, V.
    Vandenbroucke, E.
    CURRENT ONCOLOGY, 2008, 15 (04) : 196 - 197
12345